Fix the 340B Drug Pricing Program to ensure patients always benefit
The well-intentioned 340B program was initially created to help certain safety-net providers increase access to medicines for needy patients. Despite the program’s intended purpose to serve low-income and vulnerable patients, dismal oversight and reporting standards have allowed covered entities to profit while leaving patients behind. In fact, the majority of 340B DSH hospitals provide less charity care than the national average and are often not located in medically underserved areas. It is past time policymakers listen to the evidence: 340B is not working for vulnerable patients.